We compared the gene expression patterns of oxaliplatin-resistant cell lines with the patterns of their sensitive counterparts in an attempt to discover universal mechanisms that characterize ...

【引用本文】王 权，李 爽. 免疫治疗时代Ⅳ期胃癌转化治疗方案选择[J]. 中国实用外科杂志,2024,44(10):1129-1133.  摘要 ...

All medicines have risks and benefits. Your doctor has weighed the risks of you using oxaliplatin against the benefits they expect it will have for you. If you have any concerns about taking this ...

Thirty-five patients did not advance to study treatment after oxaliplatin most commonly due to withdrawing consent (n=15), disease progression (n=7), and other reasons (n=13) (12 in GRANITE arm; 23 in ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2 Long COVID Results Expected Soon Dogwood Therapeutics, Inc.

Additionally, other clinical and non-clinical data suggest BXQ-350 has activity in chemotherapy-induced peripheral neuropathy, an area of high unmet medical need in patients treated with oxaliplatin ...

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant ...

Ferroptosis offers new strategies to combat treatment resistance in digestive tract cancers, enhancing the efficacy of ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

These include the taxanes, such as paclitaxel, often used to treat breast, ovarian, prostate and lung cancers; as well as alkylating agents, including oxaliplatin, used to treat colorectal, stomach or ...